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Re: JSLS. 2009;13(2):203-206 Laparoscopic Mucin Re-
moval in Patients With Pseudomyxoma Peritonei
Dear Dr Michael S. Kavic:
This letter is regarding an article that appeared in Laparo-
scopic mucin removal in patients with pseudomyxoma
peritonei. JSLS. 2009;13(2):203-206 by Kotani Y et al. from
the Department of Obstetrics and Gynecology, Kinki Uni-
versity School of Medicine, Osaka-sayama, Osaka, Japan.
I write to you as a former patient of Pseudomyxoma
Peritonei (PMP) and a member of many patient/research
support organization for this disease and other peritoneal
surface malignancies. The standard of care for PMP is
cytoreductive surgery (CRS) with hyperthermic intraperi-
toneal chemotherapy (HIPEC). The efficacy and superior-
ity of this treatment have been established by many stud-
ies across the world compared with serial debulking. The
outcome of this treatment has shown survival rates of 85%
in 20 year, according to the latest follow-up studies. At
least 2 randomized trials and many multicentric studies
support this claim. It has shown so much promise for PMP
that it is now being extended to patients with peritoneal
carcinomatosis from colon, gastric and ovarian cancer.
The latest development in PMP is heading towards a more
proactive and preventive outlook. It has been established
that with this disease, minimally invasive procedures
could only be justified for terminal cases.
The article in question makes largely false claims about
the outcome of the standard treatment for PMP and clearly
ignores the most relevant studies available today. Where
recent studies have been cited, information from these
studies was selected with deliberate bias to fit a dubious
conclusion. Furthermore, there is a clear confusion be-
tween the studies on serial debulking, and those on cy-
toreductive surgery with HIPEC. The authors seem to use
the unacceptable outcomes of the earlier to dismiss the
latter. Sweeping claims about the disease’s pathology
were made without care for important details.
On the more specific methodological aspect of this study,
the series of patients is too small to warrant any conclu-
sions. Yet the authors allow themselves to conclude that
laparoscopic removal of mucin may be better than surgi-
cal intervention. It is important to note that the series in
support of the superiority of CRS and HIPEC include as
many as 700 patients at a time. But trouble does not stop
there; the authors entirely ignore the relevant articles on
the limited use of laparoscopy for staging of PMP and
exploration of peritoneal dissemination, which is at the
core of the article’s conclusion.
In my field as a patient and research advocate, we work
very hard to educate both patients and healthcare practi-
tioners on the life-saving value of cytoreductive surgery
and HIPEC. I find it entirely disappointing that a reputable
journal like JSLS would allow publications like this one to
contribute to confusion and ignorance. The article lacks
the basic requirements of scientific credibility that I found
it imperative that I bring this matter to your attention and
the attention of your editorial staff.
Best regards,
Amani Albedah
Director of Kuwait Group for Peritoneal Surface
Malignancy
Assistant Professor in Philosophy of Science and Critical
Thinking - Kuwait University
Tel: 965-2539-8620 / 965-9992-1183
E-mail: amani.albedah@kgpsm.org/amani.albedah@gmail.
com
Authors’ Response
Dear Dr Kavic:
Thank you very much for granting us an opportunity to
respond to the letter from Dr Amani Albedah, Director of
Kuwait Group for Peritoneal Surface Malignancy, regard-
ing our paper. We would like to supplement our article
with the following information. We hope that our expla-
nation will be acceptable and convincing to Dr Amani
Albedah.
Pseudomyxoma peritonei (PMP) is a rare disease that is char-
acterized by the collection of a large amount of mucinous
material in the abdominal cavity, whether benign or malig-
nant.
The accepted treatment methods for PMP include cytoreduc-
tion surgery and intraperitoneal chemotherapy,
1,2 but their
superiority as initial therapy or in cases with repeated recur-
rences has not been verified in randomized controlled trials
(RCTs).
Pathologically, PMP is benign or malignant. In malignant PMP,
cytoreduction surgery and chemotherapy have been shown to
be useful. All of the PMP cases that we managed were benign.
Recently, PMP with benign tumors have been referred to as
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2 It has
been reported that cytoreduction surgery and intraperitoneal
chemotherapy improve survival of patients with DPAM,
3 but
the studies were not RCTs with a high level of evidence. There
are no reports that show clear evidence for the treatment of
PMP with benign tumors.
We accept the use of cytoreduction surgery and chemother-
apy as initial therapy for PMP. For cases that have residual
lesions and repeat recurrences, there is no useful treatment
method that can significantly improve the prognosis. For pa-
tients who have a poor prognosis and repeat recurrences,
repeat laparotomy is highly invasive. Thus, we performed
laparoscopic mucin removal for patients with benign PMP
with repeat recurrences. As a minimally invasive procedure,
laparoscopy can be performed repeatedly, and can be used to
remove mucin throughout the abdominal cavity by changing
the position of the trocar.
We consider that laparoscopic surgery for PMP may not sig-
nificantly improve the prognosis but is useful as a means to
relieve symptoms.
1. Sugarbaker PH, Ronnett BM, Archer A, et al.
Pseudomyxoma peritonei syndrome. Adv Surg. 1996;30:233-
280.
2. Ronenett BM, Zahn CM, Kurman RJ, et al. Disseminated
peritoneal adenomucinosis and peritoneal mucinous carcino-
matosis. A clinicopathologic analysis of 109 cases with em-
phasis on distinguishing pathologic features, site of origin,
prognosis, and relationship to “pseudomyxoma peritonei”.
Am J Surg Pathol. 1995;19:1390-1408.
3. Bryant J, Clegg AJ, Sidhu MK, et al. Systematic review of
the Sugarbaker procedure for pseudomyxoma peritonei. Br J
Surg. 2005;92:153-158.
Very respectfully,
Yasushi Kotani, MD
Tel: 81-72-366-0221
Fax: 81-72-368-3745
E-mail: Y-Kotani@sanfu.med.kindai.ac.jp
Re: JSLS. 2009;13:32-35 Laparoscopic Surgery in the
Pregnant Patient: Results and Recommendations
We read with interest the paper published by Buser KB in
JSLS. 2009;13:32-35. The author is to be congratulated on
his work; this being quite an uncommon condition and
most publications in the literature are case reports. It
essentially deals with the safety and efficacy of laparo-
scopic procedures in pregnant patients. An important
message conveyed is the safety of laparoscopy in the third
trimester as well, while the current recommendation states
that the second trimester is ideal for any surgical interven-
tion. This series of laparoscopy in pregnancy represents
the largest reported so far.
Interestingly, our series was the largest until this paper
was published.
1 Also in our paper, we presented for the
first time 2 unique cases: laparoscopic mesh repair for
diaphragmatic hernia and laparoscopic seromyotomy for
achalasia cardia.
Because Dr Buser is discussing the role of advanced lapa-
roscopy in pregnancy, we thought he might have men-
tioned these cases.
In acute appendicitis without complications, we have
quoted the rate of fetal loss as 0% to 1.5%,
2 whereas Dr
Buser has stated 3% to 5% in his article.
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India
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Author’s Response
First, I would like to thank you for your kind consider-
ation of my paper reporting on my results for laparo-
scopic surgery in the pregnant patient. I would agree
that your series, and that detailed in my paper, indicate
that the fetal loss rates in cases of acute appendicitis are
probably lower than the range reported in the previous
literature reviews. I agree that the types of highly ad-
vanced laparoscopic procedures upon which you have
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